Gastric cancer combination therapy: synthesis of a hyaluronic acid and cisplatin containing lipid prodrug coloaded with sorafenib in a nanoparticulate system to exhibit enhanced anticancer efficacy and reduced toxicity
about
Gastric cancer combination therapy: synthesis of a hyaluronic acid and cisplatin containing lipid prodrug coloaded with sorafenib in a nanoparticulate system to exhibit enhanced anticancer efficacy and reduced toxicity
description
article
@en
im Januar 2018 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2018
@uk
name
Gastric cancer combination the ...... efficacy and reduced toxicity
@en
Gastric cancer combination the ...... efficacy and reduced toxicity
@nl
type
label
Gastric cancer combination the ...... efficacy and reduced toxicity
@en
Gastric cancer combination the ...... efficacy and reduced toxicity
@nl
prefLabel
Gastric cancer combination the ...... efficacy and reduced toxicity
@en
Gastric cancer combination the ...... efficacy and reduced toxicity
@nl
P2093
P2860
P921
P356
P1476
Gastric cancer combination the ...... efficacy and reduced toxicity
@en
P2093
P2860
P304
P356
10.2147/DDDT.S176879
P407
P577
2018-01-01T00:00:00Z